Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 11, 2023
Thermo Fisher Scientific announced it has expanded its manufacturing capacity in St. Louis to support biologic therapies for diseases ranging from cancers to auto immune conditions to rare genetic disorders.
read more
Wednesday, December 16, 2020
Provepharm Life Solutions has announced its acquisition of Apollo Pharmaceuticals USA, a company that specializes in the commercialization of sterile injectable products for hospital use.
read more
The WCG™ Clinical Services Division will offer its benchmarking solution to companies that discover and develop vaccines.
read more
Thursday, November 01, 2012
Novartis announced today the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture ...
read more
Thursday, December 22, 2016
Moffitt Cancer Center has chosen Cryoport, Inc. to provide support for its immunology program, cancer research, and therapy programs and lab moves.
read more
Cryoport, Inc. has acquired Cell&Co BioServices, headquartered in Clermont-Ferrand, France with additional operations in Pont-du-Château, France.
read more
Thursday, August 09, 2018
Gerald Schneider has joined CRB Group GmbH as the managing director for European commercial operations.
read more
Tuesday, December 29, 2020
Harbour BioMed and Utrecht University announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the prevention and treatment of COVID-19.
read more
IMS Health and Quintiles have announced that their respective boards of directors approved a definitive merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction.
read more
Crown Bioscience has announced the strengthening of its global Immuno-Oncology Platform at all its key facilities in Europe, USA, and Asia to support client’s needs with a comprehensive collection of validated models and services for in vivo ...
read more
Friday, February 17, 2017
SYMBIOSIS Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology companies for its vial-filling expertise.
read more
NorthStar Medical Radioisotopes announced completion of construction on its 20,000 square foot Mo-99 processing facility in Beloit, Wis., with equipment installation currently underway.
read more
Hikma and Civica Rx have announce a five-year agreement to manufacture and supply Civica's growing membership of US health systems with medications that are often in short supply in US hospitals.
read more
Tuesday, October 08, 2019
TrakCel and WuXi AppTec announced an agreement designed to accelerate the seamless delivery of advanced therapy treatments to bring an end-to-end solution to mutual customers.
read more
Wednesday, September 05, 2018
Over the past 25 years, globalization of drug manufacturing has prompted the FDA to change its regulatory landscape.
read more